Showing results (201-210 of 537) with videos related to

Sort By:
Pageof 54
Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia|October 4, 2008
A possible role for vaccination in the treatment of psoriasis?B S Baker, A V P Owles, L Fry
Immunology Today|October 8, 2014
Psoriasis: a disease of abnormal Keratinocyte proliferation induced by T lymphocytesH Valdimarsson, B S Bake, I Jónsdótdr, et al.
Nature Communications|November 22, 2014
VAV-1 acts in a single interneuron to inhibit motor circuit activity in Caenorhabditis elegansAmanda L Fry, Jocelyn T Laboy, Kenneth R Norman
The Journal of Clinical Investigation|October 1, 1992
Human skin levels of retinoic acid and cytochrome P-450-derived 4-hydroxyretinoic acid after topical application of retinoic acid in vivo compared to concentrations required to stimulate retinoic acid receptor-mediated transcription in vitroE A Duell, A Aström, C E Griffiths, et al.
The Journal of Investigative Dermatology|December 18, 1998
Differential expression of peroxisome proliferator-activated receptor subtypes during the differentiation of human keratinocytesM Rivier, I Safonova, P Lebrun, et al.
The British Journal of Dermatology|September 1, 1999
Clinical measures of disease severity and outcome in psoriasis: a critical appraisal of their qualityD M Ashcroft, A L Wan Po, H C Williams, et al.
The British Journal of Dermatology|September 1, 1999
Tumour necrosis factor-alpha induces Langerhans cell migration in humansM Cumberbatch, C E Griffiths, S C Tucker, et al.
The British Journal of Dermatology|May 3, 2000
The Salford Psoriasis Index: an holistic measure of psoriasis severityB Kirby, D G Fortune, M Bhushan, et al.
The British Journal of Dermatology|September 5, 2001
Efficacy of sirolimus (rapamycin) administered concomitantly with a subtherapeutic dose of cyclosporin in the treatment of severe psoriasis: a randomized controlled trialS Reitamo, P Spuls, B Sassolas, et al.
Pharmacoeconomics|January 11, 2001
Cost-effectiveness analysis of topical calcipotriol versus short-contact dithranol. In the treatment of mild to moderate plaque psoriasisD M Ashcroft, A Li Wan Po, H C Williams, et al.
Pageof 54